Profile data is unavailable for this security.
About the company
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
- Revenue in USD (TTM)787.97m
- Net income in USD163.50m
- Incorporated2009
- Employees1.47k
- LocationShockwave Medical Inc5403 Betsy Ross DrSANTA CLARA 95054United StatesUSA
- Phone+1 (510) 279-4262
- Fax+1 (302) 636-5454
- Websitehttps://shockwavemedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stevanato Group SpA | 1.17bn | 146.90m | 6.82bn | 5.64k | 40.78 | -- | 35.61 | 5.84 | 0.554 | 0.554 | 4.40 | -- | -- | -- | -- | 207,404.80 | -- | -- | -- | -- | 30.81 | -- | 12.57 | -- | -- | 32.91 | -- | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| MSA Safety Inc | 1.80bn | 266.82m | 7.44bn | 5.10k | 28.09 | 7.51 | 22.65 | 4.13 | 6.73 | 6.73 | 45.49 | 25.26 | 0.8281 | 2.86 | 6.45 | 353,467.80 | 12.26 | 5.08 | 14.25 | 6.00 | 48.05 | 45.21 | 14.81 | 7.02 | 1.54 | 6.50 | 0.3747 | 65.91 | 17.00 | 5.65 | -67.41 | -13.66 | 4.72 | -1.10 |
| Penumbra Inc | 1.10bn | 93.39m | 7.94bn | 4.20k | 86.15 | 6.59 | 65.27 | 7.24 | 2.38 | 2.38 | 27.90 | 31.05 | 0.7366 | 1.03 | 5.49 | 260,899.80 | 6.28 | 2.32 | 6.98 | 2.61 | 65.04 | 63.90 | 8.52 | 3.17 | 3.51 | -- | 0.0207 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
| Globus Medical Inc | 1.90bn | 66.63m | 8.61bn | 5.00k | 100.87 | 2.20 | 34.50 | 4.54 | 0.632 | 0.632 | 15.48 | 29.04 | 0.5353 | 1.26 | 5.01 | 379,690.80 | 1.88 | 6.90 | 2.17 | 7.45 | 62.14 | 71.73 | 3.51 | 14.05 | 1.29 | -- | 0.0977 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
| Henry Schein, Inc. | 12.45bn | 388.00m | 9.40bn | 25.00k | 24.72 | 2.61 | 14.19 | 0.7546 | 2.96 | 2.96 | 95.11 | 28.02 | 1.33 | 4.74 | 8.00 | 498,040.00 | 4.20 | 6.09 | 6.80 | 10.44 | 31.38 | 30.04 | 3.16 | 4.40 | 1.02 | 8.26 | 0.3207 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
| Teleflex Inc | 3.00bn | 296.02m | 9.77bn | 14.50k | 33.14 | 2.17 | 17.94 | 3.25 | 6.26 | 6.23 | 63.41 | 95.61 | 0.417 | 2.14 | 6.99 | 206,993.50 | 4.11 | 5.86 | 4.47 | 6.42 | 55.70 | 55.04 | 9.86 | 14.62 | 1.41 | 7.67 | 0.2808 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Insulet Corp | 1.78bn | 234.00m | 11.28bn | 3.00k | 50.13 | 14.26 | 36.56 | 6.33 | 3.21 | 3.21 | 23.61 | 11.29 | 0.7249 | 1.36 | 6.62 | 593,566.70 | 9.53 | 2.71 | 11.42 | 3.14 | 68.86 | 65.81 | 13.14 | 4.28 | 2.75 | 65.58 | 0.6393 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Shockwave Medical Inc | 787.97m | 163.50m | 12.40bn | 1.47k | 77.42 | 16.08 | 70.77 | 15.74 | 4.27 | 4.27 | 20.58 | 20.55 | 0.6493 | 1.05 | 7.55 | 536,763.60 | 13.47 | 10.29 | 14.91 | 11.39 | 86.99 | 84.69 | 20.75 | 15.14 | 12.61 | -- | 0.4936 | 0.00 | 49.11 | 126.45 | -31.81 | -- | 72.88 | -- |
| Hologic Inc | 3.96bn | 466.50m | 17.64bn | 6.99k | 38.88 | 3.64 | 22.46 | 4.45 | 1.94 | 1.94 | 16.30 | 20.76 | 0.4361 | 2.66 | 5.82 | 566,609.40 | 5.14 | 11.40 | 5.74 | 13.38 | 55.12 | 60.29 | 11.78 | 20.95 | 3.29 | -- | 0.3465 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Baxter International Inc | 14.89bn | -38.00m | 18.05bn | 60.00k | -- | 2.21 | 14.46 | 1.21 | -0.0762 | 5.21 | 29.33 | 16.04 | 0.5311 | 3.21 | 5.71 | 248,200.00 | -0.107 | 0.1942 | -0.1338 | 0.2333 | 36.31 | 38.20 | -0.2015 | 0.3674 | 1.01 | 3.58 | 0.625 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Cooper Companies Inc | 3.67bn | 290.80m | 18.45bn | 15.00k | 93.81 | 2.40 | 27.72 | 5.03 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 3.58m | 9.56% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 3.34m | 8.91% |
| Wellington Management Co. LLPas of 31 Mar 2024 | 2.61m | 6.96% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 2.52m | 6.73% |
| Artisan Partners LPas of 31 Mar 2024 | 1.53m | 4.08% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.09m | 2.91% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 743.48k | 1.98% |
| Geode Capital Management LLCas of 31 Mar 2024 | 626.67k | 1.67% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 585.00k | 1.56% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 580.23k | 1.55% |
